Close Menu
    What's Hot

    Heat intensifies severe drought across European nations

    July 24, 2026

    Amazon wildfires in Brazil fall to lowest level in four decades

    July 23, 2026

    Private sector wage growth hits six year low in latest UK data

    July 22, 2026
    Facebook X (Twitter) Instagram
    Liberia SunLiberia Sun
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Liberia SunLiberia Sun
    Home » Nomination period for the Broermann Medical Innovation Award started
    news aktuell

    Nomination period for the Broermann Medical Innovation Award started

    January 17, 2025
    Facebook Twitter Pinterest Reddit Telegram LinkedIn Tumblr VKontakte WhatsApp Email
    • Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
    • Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields

    Newszy: Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.

    The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.

    The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.

    The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. “With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases,” says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: “Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide.”

    Nomination process and deadlines

    Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.

    Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org.

    For further information, please contact

    Broermann Medical Innovation Award

    Mirjam Malko

    Tel.: +49 (0) 641 / 985-42310

    E-Mail: contact@broermann-award.org

    Asklepios Kliniken

    Corporate Communications and Marketing

    Tel.: + 49 (0) 40 / 18 18-82 66 36

    E-Mail: presse@asklepios.com

    24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888

    Visit Asklepios on the Internet, Facebook or YouTube:

    www.asklepios.com

    www.asklepios.com/konzern/gesundheitsmagazin

    www.facebook.com/asklepioskliniken

    www.youtube.com/asklepioskliniken

    RHÖN-KLINIKUM AG

    Corporate Communications and Marketing

    Heike Ochmann

    Press Spokeswoman

    Tel.: +49 (0) 9771 / 65-12130

    E-Mail: heike.ochmann@rhoen-klinikum-ag.com

    MEDICLIN AG

    Dr. Janina Lossen
    Press Spokeswoman

    Tel:. +49 (0) 781 / 488-180
    E-Mail: presse@mediclin.de

    UKGM
    Frank Steibli
    Head of Communications and Press Spokesman

    Tel.: +49 (0) 641 / 985-51020
    Mobile: +49 (0) 160 / 7120456
    E-Mail: frank.steibli@uk-gm.de

    Share. Facebook Twitter Pinterest LinkedIn Reddit Email

    Related Posts

    Canada must reduce reliance on extractive industries and U.S. exports, report finds

    April 17, 2025

    PROFESSIONAL LABELLING ANYWHERE, ANYTIME: DYMO® INTRODUCES NEW LABELMANAGER EXECUTIVE 640 CB

    March 3, 2025

    ZAIN KSA BECOMES INTER PARTNER FOR 2024/25 SEASON IN CLUB’S FIRST SAUDI ARABIA AGREEMENT

    January 23, 2025

    DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS

    January 22, 2025
    Latest News

    Heat intensifies severe drought across European nations

    July 24, 2026

    Amazon wildfires in Brazil fall to lowest level in four decades

    July 23, 2026

    Private sector wage growth hits six year low in latest UK data

    July 22, 2026

    UN urges fair rules for artificial intelligence worldwide

    July 18, 2026
    © 2026 Liberia Sun | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.